Divi's Laboratories has put up a good show during the first quarter ended June 2012 and its net profit jumped by 62.2 per cent to Rs.167.38 crore from Rs.102.59 crore in the similar period of last year. Its EBDITA also increased by 60.8 per cent to Rs.232.20 crore from Rs.144.38 crore. The net sales increased by 29.7 per cent to Rs.468.41 crore from Rs.361.28 crore. With significant growth profits, its earnings per share improved to Rs.12.61 from Rs.7.74 in the last period.

Divi's Unit-2 near Visakhaptnam has undergone 3 cGMP inspections during June-July 2012. One of the inspections was by TGA of Australia for active pharma ingredients. The other 2 inspections were by US FDA, one for nutraceuticals and the other for active pharma ingredients. All the 3 inspections had no major observations.